Tag: Obesity
Metabolic Surgery Has Greater Long-Term Benefits Than GLP-1 Receptor Agonists
Findings seen for long-term outcomes among adult patients with diabetes and obesity
Patients With Extreme Obesity Face Limitations to Accessing Specialty Care
41 percent of practices declined to schedule appointment for hypothetical patient weighing 465 lb; 52 percent lacked basic standards of care
Oral Semaglutide Effective for Weight Loss in Overweight or Obesity
Estimated mean change in body weight from baseline to week 64 was −13.6 and −2.2 percent with oral semaglutide and placebo, respectively
Oral Orforglipron Yields Greater Weight Reductions Than Placebo
Significant mean change in body weight from baseline to week 72 seen with various dosages of orforglipron compared with placebo among adults with obesity
GLP-1 Receptor Agonists Improve Glycemic, Weight Outcomes in Children With T2D
Glycemic, weight, cardiometabolic outcomes improved for children and teens with obesity, prediabetes, or T2D
Once-Weekly Semaglutide 7.2 mg Beats Placebo for Obesity
Second study shows 7.2 mg semaglutide leads to greater reductions in mean body weight for those with obesity, T2D
Weight-Loss Surgery Bests Medical Weight Management for Obesity-Related Risk Mitigation
Significantly lower risk seen for developing major metabolic comorbidities
GLP-1 RAs Cost-Effective Versus Usual Care for Knee OA, Obesity
Tirzepatide offers more favorable return on investment, but greater benefits seen at lower costs for Roux-en-Y gastric bypass
Without Biannual Time Shift, Prevalence of Obesity, Stroke May Be Reduced
Modeling study shows decrease in prevalence of both obesity and stroke under Standard Time, Daylight Saving Time versus current policy
Parent-Focused Interventions Do Not Prevent Obesity at Age 24 Months
Review and meta-analysis show parent-focused interventions insufficient for preventing obesity in young children
